101 related articles for article (PubMed ID: 24881923)
1. [Clinical experience of bendamustine for adult Langerhans cell sarcoma].
Miyazawa Y; Tahara K; Yuzuriha A; Mihara M; Toyama K; Yokohama A; Handa H; Jinbo T
Rinsho Ketsueki; 2014 May; 55(5):563-9. PubMed ID: 24881923
[TBL] [Abstract][Full Text] [Related]
2. Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation.
Sala E; Crocchiolo R; Gandolfi S; Bruno-Ventre M; Bramanti S; Peccatori J; Sarina B; Corti C; Ciceri F; Santoro A; Marktel S; Castagna L
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1444-7. PubMed ID: 24907625
[TBL] [Abstract][Full Text] [Related]
3. [Durable remission of Langerhans cell sarcoma attained by autologous hematopoietic stem cell transplantation following surgical resection].
Fuseya H; Nakao T; Tsutsumi M; Nakaya Y; Horiuchi M; Yoshida M; Yoshimura T; Hayashi Y; Fukushima H; Inoue T; Aiba T; Yamane T
Rinsho Ketsueki; 2019; 60(4):314-318. PubMed ID: 31068562
[TBL] [Abstract][Full Text] [Related]
4. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
Hartmann JT; Mayer F; Schleicher J; Horger M; Huober J; Meisinger I; Pintoffl J; Käfer G; Kanz L; Grünwald V;
Cancer; 2007 Aug; 110(4):861-6. PubMed ID: 17599772
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine hydrochloride - a renaissance of alkylating strategies in anticancer medicine.
Eichbaum M; Bischofs E; Nehls K; Schneeweiss A; Sohn C
Drugs Today (Barc); 2009 Jun; 45(6):431-44. PubMed ID: 19649333
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma.
Corazzelli G; Angrilli F; D'Arco A; Ferrara F; Musto P; Guarini A; Cox MC; Stelitano C; Storti S; Iannitto E; Falorio S; Califano C; Amore A; Arcamone M; De Filippi R; Pinto A
Br J Haematol; 2013 Jan; 160(2):207-15. PubMed ID: 23167437
[TBL] [Abstract][Full Text] [Related]
7. [Langerhans cell sarcoma developing acute myeloid leukemia after achieving complete response by THP-COP].
Hamaguchi K; Hashimoto A; Fujimi A; Kanisawa Y; Shibata T; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Kamihara Y; Ohshima K; Kato J
Rinsho Ketsueki; 2015 Dec; 56(12):2456-61. PubMed ID: 26725355
[TBL] [Abstract][Full Text] [Related]
8. Langerhans cell sarcoma: a systematic review.
Howard JE; Dwivedi RC; Masterson L; Jani P
Cancer Treat Rev; 2015 Apr; 41(4):320-31. PubMed ID: 25805533
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cell sarcoma arising from antecedent langerhans cell histiocytosis: A case report.
Yi W; Chen WY; Yang TX; Lan JP; Liang WN
Medicine (Baltimore); 2019 Mar; 98(10):e14531. PubMed ID: 30855438
[TBL] [Abstract][Full Text] [Related]
10. Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi.
Anastasia A; Carlo-Stella C; Corradini P; Salvi F; Rusconi C; Pulsoni A; Hohaus S; Pregno P; Viviani S; Brusamolino E; Luminari S; Giordano L; Santoro A
Br J Haematol; 2014 Jul; 166(1):140-2. PubMed ID: 24606548
[No Abstract] [Full Text] [Related]
11. Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.
Bottke D; Bathe K; Wiegel T; Hinkelbein W
Strahlenther Onkol; 2007 Mar; 183(3):128-32. PubMed ID: 17340070
[TBL] [Abstract][Full Text] [Related]
12. Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy.
Lissitchkov T; Arnaudov G; Peytchev D; Merkle Kh
J Cancer Res Clin Oncol; 2006 Feb; 132(2):99-104. PubMed ID: 16292542
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning.
Veys PA; Nanduri V; Baker KS; He W; Bandini G; Biondi A; Dalissier A; Davis JH; Eames GM; Egeler RM; Filipovich AH; Fischer A; Jürgens H; Krance R; Lanino E; Leung WH; Matthes S; Michel G; Orchard PJ; Pieczonka A; Ringdén O; Schlegel PG; Sirvent A; Vettenranta K; Eapen M
Br J Haematol; 2015 Jun; 169(5):711-8. PubMed ID: 25817915
[TBL] [Abstract][Full Text] [Related]
14. Bendamustine--a new approach to the treatment of advanced hepatocellular carcinoma?
Wiedmann M; Zeh J; Schoppmeyer K; Moebius C; Niederhagen M; Wittekind C; Mossner J; Caca K
J Chemother; 2008 Feb; 20(1):112-8. PubMed ID: 18343753
[TBL] [Abstract][Full Text] [Related]
15. Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
Poenisch W; Plötze M; Holzvogt B; Andrea M; Schliwa T; Zehrfeld T; Hammerschmidt D; Schwarz M; Edelmann T; Becker C; Hoffmann FA; Schwarzer A; Kreibich U; Gutsche K; Reifenrath K; Schwarzbach H; Heyn S; Franke GN; Jentzsch M; Leiblein S; Schwind S; Lange T; Vucinic V; AlAli HK; Niederwieser D
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2013-22. PubMed ID: 25976868
[TBL] [Abstract][Full Text] [Related]
16. Bendamustine: rebirth of an old drug.
Cheson BD; Rummel MJ
J Clin Oncol; 2009 Mar; 27(9):1492-501. PubMed ID: 19224851
[TBL] [Abstract][Full Text] [Related]
17. Bendamustine: something old, something new.
Tageja N; Nagi J
Cancer Chemother Pharmacol; 2010 Aug; 66(3):413-23. PubMed ID: 20376452
[TBL] [Abstract][Full Text] [Related]
18. [Long-term remission of Langerhans cell sarcoma by AIM regimen combined with involved-field irradiation].
Shimizu I; Takeda W; Kirihara T; Sato K; Fujikawa Y; Ueki T; Sumi M; Ueno M; Ichikawa N; Kobayashi H; Watanabe M; Uehara T; Nakamura S
Rinsho Ketsueki; 2012 Nov; 53(11):1911-5. PubMed ID: 23257672
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Ogura M; Uchida T; Taniwaki M; Ando K; Watanabe T; Kasai M; Matsumoto Y; Shimizu D; Ogawa Y; Ohmachi K; Yokoyama H; Tobinai K;
Cancer Sci; 2010 Sep; 101(9):2054-8. PubMed ID: 20594195
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer.
Klippstein A; Schneider CP; Sayer HG; Höffken K
J Cancer Res Clin Oncol; 2003 May; 129(5):316-9. PubMed ID: 12756557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
